accessibility menu, dialog, popup

UserName
Viewing profile as user:

Naphthalenes

Polycyclic aromatic hydrocarbon compounds that consist of ten carbon atoms and eight hydrogen atoms fused into two benzene rings; it is the simplest polycyclic aromatic hydrocarbon.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (8)
  • (2)

special interests

  • (8)

Search Within Results
Keyword Search:
1 – 10 of 10 results
1

Medchemexpress LLC Acebutolol (hydrochloride) | 34381-68-5 | 99.7% | 372.89 | 1 G
SDP

Acebutolol hydrochloride is an orally active β1 adrenergic receptor (β1AR) antagonist. It is used in the treatment of hypertension, angina pectoris, and cardiac arrhythmias. It acts as a beta blocker and has been shown to decrease cardiac output and significantly reduce regional blood flow in in vivo studies.

  • Orally active β1 adrenergic receptor (β1AR) antagonist
  • Used to treat hypertension
  • Used to treat angina pectoris
  • Used to treat cardiac arrhythmias
  • Beta blocker for hypertension and arrhythmias
  • Decreases cardiac output in in vivo studies
  • Reduces regional blood flow in in vivo studies

ENCOMPASS_PREFERRED
2

Medchemexpress LLC Acebutolol hydrochloride | 34381-68-5 | 99.70% | 372.89 | 25 MG
SDP

Acebutolol hydrochloride is an orally active β1 adrenergic receptor (β1AR) antagonist. It is used in the treatment of hypertension, angina pectoris, and cardiac arrhythmias.

  • Orally active β1 adrenergic receptor (β1AR) antagonist
  • Used in the treatment of hypertension
  • Used in the treatment of angina pectoris
  • Used in the treatment of cardiac arrhythmias
  • Launched for clinical use

ENCOMPASS_PREFERRED
3

Medchemexpress LLC Acebutolol hydrochloride | 34381-68-5 | MFCD00078860 | 99.7% | 372.89 | 500 MG
SDP

Acebutolol hydrochloride is an orally active β1 adrenergic receptor (β1AR) antagonist used to treat hypertension, angina pectoris, and cardiac arrhythmias.

  • Appearance: solid
  • Color: white to off-white
  • Shipping: room temperature in continental US; may vary elsewhere
  • Storage: 4°C, sealed storage, away from moisture
  • In solvent: -80°C for 6 months; -20°C for 1 month (sealed storage, away from moisture)
  • Solubility in DMSO: 100 mg/mL (268.18 mM)
  • Solubility in H2O: ≥ 50 mg/mL (134.09 mM)

ENCOMPASS_PREFERRED
4

eMolecules​ ethyl 5-bromobenzo[b]thiophene-2-carboxylate | 13771-68-1 | MFCD12756246 | 5g

WuXi ChemSupply | ethyl 5-bromobenzo[b]thiophene-2-carboxylate | 5g | 599165527 | LN00187729 | 95.000 | 13771-68-1 | MFCD12756246 | 285.160 | C11H9BrO2S

If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool

ENCOMPASS_PREFERRED
5

Medchemexpress LLC 5-hydroxy-4H-1,4-benzoxazin-3-one derivative (substituted amine) | 1202235-68-4 | 99.6% | 25 MG
SDP

BI-167107 is a high-affinity full agonist of the β2 adrenergic receptor (β2AR) with a reported dissociation constant of approximately 84 pM. Supplied as a high-purity solid for research use, it is commonly used as a pharmacology and structural biology tool because of its slow dissociation rate and strong receptor affinity.

  • High-affinity β2AR full agonist with Kd ≈ 84 pM.
  • High purity solid suitable for biochemical assays and structural studies.
  • Available in small milligram pack sizes for research use.
  • Soluble in DMSO; available as a 10 mM solution format for assay preparation.
  • Molecular weight 370.4 g/mol; formula C21H26N2O4.
  • Used as a tool compound for receptor pharmacology and crystallography due to very slow off-rate.

ENCOMPASS_PREFERRED
6

eMolecules​ Synthonix - Stock 2-chloro-5-(tributylstannyl)pyrimidine 5g 525912781 C2264 155191-68-7 MFCD07787378 403.580 C16H29ClN2Sn

Synthonix - Stock 2-chloro-5-(tributylstannyl)pyrimidine 5g 525912781 C2264 155191-68-7 MFCD07787378 403.580 C16H29ClN2Sn

ENCOMPASS_PREFERRED
7

Medchemexpress LLC 2-Oxa-5-azabicyclo[2.2.1]heptane, 5-[2-[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-6-[6-(4-methoxy-3-pyri | 2769715-68-4 | 99.3% | 592.69 | 25 MG
SDP

BI-4732 is an orally active, reversible, ATP-competitive EGFR inhibitor with blood-brain barrier penetration. It inhibits the kinase activity of EGFR L858R, T790M, and C797S with IC50 values of 1 nM, while sparing wild-type EGFR. BI-4732 inhibits EGFR and reduces the phosphorylation of AKT, ERK, and S6K. It demonstrates excellent intracranial anti-tumor efficacy in a YU-1097 xenograft model, making it suitable for studying non-small cell lung cancer (NSCLC).

  • Orally active
  • Reversible
  • ATP-competitive EGFR inhibitor
  • Blood-brain barrier penetration
  • Inhibits kinase activity of EGFR L858R, T790M, and C797S with IC50 values of 1 nM
  • Spares wild-type EGFR
  • Reduces phosphorylation of AKT, ERK, and S6K
  • Demonstrates intracranial anti-tumor efficacy in YU-1097 xenograft model
  • Useful for the study of non-small cell lung cancer (NSCLC)

ENCOMPASS_PREFERRED
8

Medchemexpress LLC 5-hydroxy-8-(1-hydroxy-2-((2-methyl-1-(o-tolyl)propan-2-yl)amino)ethyl)-4H-benzoxazin-3-one | 1202235-68-4 | 99.6% | 1 ML
SDP

BI-167107 is a research-grade small-molecule full agonist of the β2 adrenergic receptor used as a pharmacological tool in receptor activation, signaling, and structural biology studies. It is supplied for biochemical and biophysical experiments and is typically provided at high purity.

  • High-affinity full agonist for β2 adrenergic receptor (Kd ≈ 84 pM).
  • Suitable for receptor pharmacology, crystallography, and signaling assays.
  • Molecular formula C21H26N2O4; molecular weight 370.4 g/mol.
  • High purity (≈99.6%) and white to off-white solid appearance.
  • Stable when stored at -20°C (powder) and -80°C (solutions).

ENCOMPASS_PREFERRED
9

Medchemexpress LLC (1R,4R)-5-(2-((R)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-6-(6-(4-methoxypyridin-3-yl)-4- | 2769715-68-4 | 99.3% | 592.69 g/mol | C32H36N10O2 | 10 MG
SDP

BI-4732 is an orally active, reversible, ATP-competitive EGFR inhibitor with blood-brain barrier penetration that selectively targets common mutant EGFR variants and has demonstrated intracranial antitumor efficacy in preclinical models.

  • Orally active, reversible EGFR inhibitor with blood-brain barrier penetration.
  • Selective inhibition of mutant EGFR variants including L858R, T790M, and C797S.
  • Demonstrated intracranial antitumor efficacy in xenograft models.
  • High purity (99.3%) suitable for preclinical research.
  • Solid form; soluble in DMSO at approximately 2 mg/mL with warming and sonication.
  • Recommended storage: 4°C protected from light; in solution, store at -80°C (6 months) or -20°C (1 month).

ENCOMPASS_PREFERRED
10

Medchemexpress LLC 2-Oxa-5-azabicyclo[2.2.1]heptane, 5-[2-[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-6-[6-(4-methoxy-3-pyridinyl)-4-methyl-1H-pyrazolo[4,3-c]pyridin-1-yl]-1-methyl-1H-imidazo[4,5-c]pyridin-4-yl]-, (1R,4R)- | 2769715-68-4 | 99.3% | 592.69 | 5 MG
SDP

2-Oxa-5-azabicyclo[2.2.1]heptane, 5-[2-[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-6-[6-(4-methoxy-3-pyridinyl)-4-methyl-1H-pyrazolo[4,3-c]pyridin-1-yl]-1-methyl-1H-imidazo[4,5-c]pyridin-4-yl]-, (1R,4R)- | 2769715-68-4 | 99.3% | 592.69 | 5 MG

ENCOMPASS_PREFERRED